The Use of Antisense Oligonucleotides in Evaluating Survivin as a Therapeutic Target for Radiation Sensitization in Lung Cancer
<p>Elucidating the mechanism of over and under expression of proteins is critical in developing a better understanding of cancer. Multiple techniques are used to examine differential expression of proteins in cells and assess changes in protein expression in response to therapies such as radia...
Main Authors: | Shinohara Eric T., Hallahan Dennis E., Lu Bo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2004-01-01
|
Series: | Biological Procedures Online |
Subjects: | |
Online Access: | http://www.biologicalprocedures.com/bpo/arts/1/95/m95.pdf |
Similar Items
-
Down-regulation of Survivin by Antisense Oligonucleotides Increases Apoptosis, Inhibits Cytokinesis and Anchorage-Independent Growth
by: Jun Chen, et al.
Published: (2000-05-01) -
Quantitative Analysis of Survivin Protein Expression and Its Therapeutic Depletion by an Antisense Oligonucleotide in Human Lung Tumors
by: Anna L Olsen, et al.
Published: (2012-01-01) -
Delivery of a survivin promoter-driven antisense survivin-expressing plasmid DNA as a cancer therapeutic: a proof-of-concept study
by: Lin KY, et al.
Published: (2016-05-01) -
THERAPEUTIC ANTISENSE OLIGONUCLEOTIDES AGAINST CANCER: HURDLING TO THE CLINIC
by: Pedro Miguel Duarte Moreno, et al.
Published: (2014-10-01) -
Effect of antisense oligodeoxynucleotide targeting survivin on growth of human gastric cancer cells
by: Lantao Xu
Published: (2013-01-01)